HeartSciences ratios data for the quarter ended Apr 2026. These financial ratios cover 20 quarters of results from Jul 2021 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Dec2025 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||
| Gross Margin | 23.09% | 68.83% | 69.15% | 36.38% | 61.03% | 61.03% | 68.97% | 56.78% | 60.00% | 58.33% | ||||||||||
| EBT Margin | -10,048.78% | -45,231.90% | -49,526.22% | -49,178.25% | -68,826.05% | -44,830.28% | -11,182.50% | -48,304.62% | -108,305.63% | -97,269.00% | ||||||||||
| EBIT Margin | -9,011.84% | -40,156.46% | -47,669.56% | -44,690.53% | -67,143.74% | -40,254.95% | -10,376.75% | -44,147.10% | -98,637.84% | -85,713.23% | ||||||||||
| EBITDA Margin | -9,011.84% | -40,156.46% | -47,669.56% | -44,690.53% | -67,143.74% | -40,254.95% | -10,376.75% | -44,147.10% | -98,637.84% | -85,713.23% | ||||||||||
| Operating Margin | -9,011.84% | -40,156.46% | -47,669.56% | -44,690.53% | -67,143.74% | -40,254.95% | -10,376.75% | -44,147.10% | -98,637.84% | -85,713.23% | ||||||||||
| Net Margin | -10,048.78% | -45,231.90% | -49,526.22% | -49,178.25% | -68,826.05% | -44,830.28% | -11,182.50% | -48,304.62% | -108,305.63% | -97,269.00% | ||||||||||
| FCF Margin | -9,587.00% | -35,265.62% | -28,737.58% | -56,842.34% | -52,486.77% | -25,388.18% | -14,352.14% | -36,566.44% | -102,808.79% | -96,497.15% | ||||||||||
| Efficiency | ||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.68M | 0.68M | 0.68M | 0.68M | 0.68M | 0.68M | 0.67M | 0.65M | 0.64M | 0.65M | 0.65M | 0.65M | 0.65M | 0.65M | 0.65M | 0.65M | ||||
| Assets AverageAssets Avg. | 3.83M | 5.17M | 4.13M | 3.38M | 2.94M | 2.48M | 6.58M | 10.15M | 8.85M | 7.98M | 6.74M | 4.96M | 5.33M | 6.22M | 5.11M | |||||
| Invested CapitalInvested Cap. | 0.02M | 4.02M | 2.21M | 0.87M | 1.23M | 0.48M | -0.23M | 9.13M | 7.82M | 6.43M | 6.43M | 4.31M | 2.76M | 4.68M | 4.68M | 2.76M | 6.97M | |||
| Asset Utilization RatioAsset Util. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Leverage & Solvency | ||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -8.69 | -12.28 | -7.91 | -25.67 | -9.96 | -54.10 | -39.91 | -47.08 | -36.70 | -8.80 | -12.88 | -89.78 | -92.15 | -16.88 | -13.21 | -10.62 | -10.20 | -7.42 | -11.11 | |
| Debt Ratio | 2.91 | 0.20 | 0.24 | 0.32 | 0.30 | 0.38 | 0.60 | 0.05 | 0.05 | 0.06 | 0.31 | 0.44 | 0.60 | 0.24 | 0.08 | 0.60 | ||||
| Times Interest Earned | -8.69 | -12.28 | -7.91 | -25.67 | -9.96 | -54.10 | -39.91 | -47.08 | -36.70 | -8.80 | -12.88 | -89.78 | -92.15 | -16.88 | -13.21 | -10.62 | -10.20 | -7.42 | -11.11 | |
| Return Ratios | ||||||||||||||||||||
| Return on Sales [ROS]ROS | -9,011.84% | -40,156.46% | -47,669.56% | -44,690.53% | -62,276.73% | -67,143.74% | -118,698.33% | -40,254.95% | -10,376.75% | -33,901.99% | -44,687.97% | -44,147.10% | -98,637.84% | -85,713.23% | -96,946.89% | |||||
| Return on Capital Employed [ROCE]ROCE | -239.03% | -309.49% | -303.36% | -394.16% | -575.60% | 554.21% | -123.49% | -75.07% | -94.07% | -159.47% | -262.27% | -662.81% | -352.01% | -177.18% | ||||||
| Return on Assets [ROA]ROA | -154.18% | -129.15% | -164.30% | -187.84% | -208.98% | -245.26% | -97.07% | -65.60% | -83.54% | -97.01% | -128.36% | -178.37% | -165.34% | -145.78% |